Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients undergoing Elective caesarean section under spinal anesthesia. 2. Age 18-40yrs. 3,ASA I andII. 4.Height -150 cm and above
Exclusion criteria
Exclusion criteria: 1.Patients refuse spinal anesthesia; unwilling to participate in study,unable to communicate. 2. Patients with localized skin infection, haemorrhagic diathesis ,neurological involvement/ gross spinal abnormality,severe anemia. 3.Patients with history of drug allergy to Bupivacaine, fentanyl and midazolam. 4.Patients with cardiac, pulmonary,hepatic or renal disorders. 5 Bad obstetric history, obstetric complications in present pregnancy, evidence of foetal compromise and anomalies. 6 Patients physically dependent on narcotics or benzodiazepines. 7.Patients unable to understand Visual analog scale.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ To evaluate post operative analgesic efficacy of Midazolam and Fentanyl as an adjuvant to Bupivacaine heavy for elective lower segment caesarean section .Timepoint: Time from administration of drug intrathecally till 24hrs. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare sensory characteristics: 1. Onset of sensory block. 2. Highest sensory level achieved.. 3. ,Time to reach highest sensory level, 4. Time of two segment regression from highest level of block 5. Total duration of sensory block. â?¢ To compare motor characteristics 1. Bromage score 2. Onset of motor blockade 3. Maximum motor blockade 4. Time to achieve maximum motor block 5. Duration of motor block â?¢ To compare the haemodynamic parameters (Pulse,SBP,DBP,MAP,Spo2 )in both groups â?¢ To assess the sedation score in both the groups. â?¢ To assess the neonatal outcome in both the groups.(APGAR SCORE) â?¢ To study the side effects of Midazolam and Fentanyl as adjuvants to Bupivacaine heavy as well as complications of spinal anesthesia.(Hypotension,bradycardia,chills,nausea,vomiting, Respiratory depression,pruritus,dryness of mouth,urinary retention) Timepoint: Time from administration of drug intrathecally till 24hrs | — |
Countries
India
Contacts
SSG Medical college and hospital,Vadodara